Papers
6
Total Citations
89
H-Index
4
About
Davide Arcaniolo is a urological surgeon whose research bridges cutting-edge surgical innovation with pressing clinical challenges. His primary focus lies in prostate cancer management, where he has made significant contributions to improving diagnostic accuracy through multiparametric MRI and fusion-targeted biopsy—a study with 47 citations that demonstrated how these techniques enhance detection rates while reducing unnecessary diagnoses. Arcaniolo is also a pioneer in minimally invasive surgery, comparing robotic-assisted versus laparoscopic simple prostatectomy (9 citations) and investigating long-term outcomes of the ProACT device for stress urinary incontinence after radical prostatectomy, with a notable 8-year follow-up analysis. His work extends beyond the operating room: during the COVID-19 pandemic, he authored a highly cited paper (22 citations) exploring how the crisis could catalyze positive reforms in urology residency training. Demonstrating remarkable interdisciplinary thinking, Arcaniolo has even examined the cardiac effects of tadalafil in prostatectomy patients, linking urology with heart failure research. His recent work on complex renal masses (2025) signals an evolving expertise in nephron-sparing surgery. With a career defined by technical precision, educational foresight, and patient-centered outcomes, Arcaniolo stands as a forward-thinking leader in modern urology.
Research Focus
Key Achievements
Top Papers
- 1
- 2How Can the COVID-19 Pandemic Lead to Positive Changes in Urology Residency?22 citations · 2020
- 3
- 4
- 5
- 6